nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Raloxifene—osteoporosis	0.0462	0.0815	CbGbCtD
Nicardipine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0446	0.0787	CbGbCtD
Nicardipine—CYP2C9—Estropipate—osteoporosis	0.0366	0.0645	CbGbCtD
Nicardipine—CYP2B6—Cholecalciferol—osteoporosis	0.0357	0.0629	CbGbCtD
Nicardipine—CYP2C8—Raloxifene—osteoporosis	0.035	0.0617	CbGbCtD
Nicardipine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0338	0.0596	CbGbCtD
Nicardipine—CYP2C8—Cholecalciferol—osteoporosis	0.027	0.0476	CbGbCtD
Nicardipine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0229	0.0403	CbGbCtD
Nicardipine—CYP2C19—Cholecalciferol—osteoporosis	0.0227	0.04	CbGbCtD
Nicardipine—CYP3A5—Estradiol—osteoporosis	0.0227	0.0399	CbGbCtD
Nicardipine—CYP2C8—Estradiol—osteoporosis	0.0218	0.0384	CbGbCtD
Nicardipine—CYP3A4—Estropipate—osteoporosis	0.0213	0.0375	CbGbCtD
Nicardipine—CYP3A4—Calcitriol—osteoporosis	0.0213	0.0375	CbGbCtD
Nicardipine—CYP2C9—Cholecalciferol—osteoporosis	0.0189	0.0332	CbGbCtD
Nicardipine—CYP2C19—Estradiol—osteoporosis	0.0183	0.0322	CbGbCtD
Nicardipine—CYP2D6—Cholecalciferol—osteoporosis	0.0172	0.0304	CbGbCtD
Nicardipine—CYP3A4—Ergocalciferol—osteoporosis	0.017	0.03	CbGbCtD
Nicardipine—ABCB1—Conjugated Estrogens—osteoporosis	0.0168	0.0296	CbGbCtD
Nicardipine—CYP2C9—Estradiol—osteoporosis	0.0152	0.0268	CbGbCtD
Nicardipine—ABCB1—Estradiol—osteoporosis	0.0147	0.026	CbGbCtD
Nicardipine—CYP3A4—Raloxifene—osteoporosis	0.0142	0.025	CbGbCtD
Nicardipine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0137	0.0242	CbGbCtD
Nicardipine—CYP3A4—Cholecalciferol—osteoporosis	0.011	0.0193	CbGbCtD
Nicardipine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0101	0.0177	CbGbCtD
Nicardipine—CYP3A4—Estradiol—osteoporosis	0.00884	0.0156	CbGbCtD
Nicardipine—Anxiety—Pamidronate—osteoporosis	0.000369	0.00157	CcSEcCtD
Nicardipine—Ill-defined disorder—Zoledronate—osteoporosis	0.000369	0.00157	CcSEcCtD
Nicardipine—Abdominal pain—Alendronate—osteoporosis	0.000368	0.00157	CcSEcCtD
Nicardipine—Body temperature increased—Alendronate—osteoporosis	0.000368	0.00157	CcSEcCtD
Nicardipine—Sinusitis—Estradiol—osteoporosis	0.000368	0.00157	CcSEcCtD
Nicardipine—Shock—Risedronate—osteoporosis	0.000368	0.00156	CcSEcCtD
Nicardipine—Discomfort—Pamidronate—osteoporosis	0.000366	0.00156	CcSEcCtD
Nicardipine—Agitation—Zoledronate—osteoporosis	0.000365	0.00155	CcSEcCtD
Nicardipine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000363	0.00154	CcSEcCtD
Nicardipine—Abdominal pain—Raloxifene—osteoporosis	0.000362	0.00154	CcSEcCtD
Nicardipine—Body temperature increased—Raloxifene—osteoporosis	0.000362	0.00154	CcSEcCtD
Nicardipine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000361	0.00154	CcSEcCtD
Nicardipine—Malaise—Zoledronate—osteoporosis	0.000358	0.00153	CcSEcCtD
Nicardipine—Body temperature increased—Ibandronate—osteoporosis	0.000358	0.00153	CcSEcCtD
Nicardipine—Abdominal pain—Ibandronate—osteoporosis	0.000358	0.00153	CcSEcCtD
Nicardipine—Confusional state—Pamidronate—osteoporosis	0.000358	0.00152	CcSEcCtD
Nicardipine—Vertigo—Zoledronate—osteoporosis	0.000357	0.00152	CcSEcCtD
Nicardipine—Syncope—Zoledronate—osteoporosis	0.000356	0.00152	CcSEcCtD
Nicardipine—Oedema—Pamidronate—osteoporosis	0.000355	0.00151	CcSEcCtD
Nicardipine—Infection—Pamidronate—osteoporosis	0.000353	0.0015	CcSEcCtD
Nicardipine—Rhinitis—Estradiol—osteoporosis	0.000353	0.0015	CcSEcCtD
Nicardipine—Palpitations—Zoledronate—osteoporosis	0.000351	0.00149	CcSEcCtD
Nicardipine—Body temperature increased—Calcitriol—osteoporosis	0.000351	0.00149	CcSEcCtD
Nicardipine—Abdominal pain—Calcitriol—osteoporosis	0.000351	0.00149	CcSEcCtD
Nicardipine—Hypoaesthesia—Estradiol—osteoporosis	0.00035	0.00149	CcSEcCtD
Nicardipine—Shock—Pamidronate—osteoporosis	0.000349	0.00149	CcSEcCtD
Nicardipine—Loss of consciousness—Zoledronate—osteoporosis	0.000349	0.00149	CcSEcCtD
Nicardipine—Hypersensitivity—Estropipate—osteoporosis	0.000348	0.00148	CcSEcCtD
Nicardipine—Thrombocytopenia—Pamidronate—osteoporosis	0.000348	0.00148	CcSEcCtD
Nicardipine—Vomiting—Etidronic acid—osteoporosis	0.000347	0.00148	CcSEcCtD
Nicardipine—Oedema peripheral—Estradiol—osteoporosis	0.000347	0.00148	CcSEcCtD
Nicardipine—Tachycardia—Pamidronate—osteoporosis	0.000347	0.00148	CcSEcCtD
Nicardipine—Rash—Etidronic acid—osteoporosis	0.000345	0.00147	CcSEcCtD
Nicardipine—Dermatitis—Etidronic acid—osteoporosis	0.000344	0.00146	CcSEcCtD
Nicardipine—Vertigo—Conjugated Estrogens—osteoporosis	0.000344	0.00146	CcSEcCtD
Nicardipine—Hyperhidrosis—Pamidronate—osteoporosis	0.000343	0.00146	CcSEcCtD
Nicardipine—Syncope—Conjugated Estrogens—osteoporosis	0.000343	0.00146	CcSEcCtD
Nicardipine—Hypertension—Zoledronate—osteoporosis	0.000343	0.00146	CcSEcCtD
Nicardipine—Hypersensitivity—Alendronate—osteoporosis	0.000343	0.00146	CcSEcCtD
Nicardipine—Headache—Etidronic acid—osteoporosis	0.000342	0.00146	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00034	0.00145	CcSEcCtD
Nicardipine—Asthenia—Estropipate—osteoporosis	0.000339	0.00144	CcSEcCtD
Nicardipine—Visual impairment—Estradiol—osteoporosis	0.000339	0.00144	CcSEcCtD
Nicardipine—Arthralgia—Zoledronate—osteoporosis	0.000338	0.00144	CcSEcCtD
Nicardipine—Chest pain—Zoledronate—osteoporosis	0.000338	0.00144	CcSEcCtD
Nicardipine—Myalgia—Zoledronate—osteoporosis	0.000338	0.00144	CcSEcCtD
Nicardipine—Palpitations—Conjugated Estrogens—osteoporosis	0.000338	0.00144	CcSEcCtD
Nicardipine—Insomnia—Risedronate—osteoporosis	0.000338	0.00144	CcSEcCtD
Nicardipine—Anxiety—Zoledronate—osteoporosis	0.000337	0.00144	CcSEcCtD
Nicardipine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000336	0.00143	CcSEcCtD
Nicardipine—Paraesthesia—Risedronate—osteoporosis	0.000335	0.00143	CcSEcCtD
Nicardipine—Discomfort—Zoledronate—osteoporosis	0.000334	0.00142	CcSEcCtD
Nicardipine—Asthenia—Alendronate—osteoporosis	0.000334	0.00142	CcSEcCtD
Nicardipine—Hypersensitivity—Ibandronate—osteoporosis	0.000334	0.00142	CcSEcCtD
Nicardipine—Dyspnoea—Risedronate—osteoporosis	0.000333	0.00142	CcSEcCtD
Nicardipine—Hypotension—Pamidronate—osteoporosis	0.000332	0.00141	CcSEcCtD
Nicardipine—Dry mouth—Zoledronate—osteoporosis	0.000331	0.00141	CcSEcCtD
Nicardipine—Dyspepsia—Risedronate—osteoporosis	0.000329	0.0014	CcSEcCtD
Nicardipine—Tinnitus—Estradiol—osteoporosis	0.000328	0.0014	CcSEcCtD
Nicardipine—Constipation—Ethinyl Estradiol—osteoporosis	0.000328	0.00139	CcSEcCtD
Nicardipine—Confusional state—Zoledronate—osteoporosis	0.000327	0.00139	CcSEcCtD
Nicardipine—Hypersensitivity—Calcitriol—osteoporosis	0.000327	0.00139	CcSEcCtD
Nicardipine—Flushing—Estradiol—osteoporosis	0.000327	0.00139	CcSEcCtD
Nicardipine—Chest pain—Conjugated Estrogens—osteoporosis	0.000326	0.00139	CcSEcCtD
Nicardipine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000326	0.00139	CcSEcCtD
Nicardipine—Myalgia—Conjugated Estrogens—osteoporosis	0.000326	0.00139	CcSEcCtD
Nicardipine—Asthenia—Ibandronate—osteoporosis	0.000325	0.00138	CcSEcCtD
Nicardipine—Anxiety—Conjugated Estrogens—osteoporosis	0.000325	0.00138	CcSEcCtD
Nicardipine—Nausea—Etidronic acid—osteoporosis	0.000325	0.00138	CcSEcCtD
Nicardipine—Oedema—Zoledronate—osteoporosis	0.000324	0.00138	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000324	0.00138	CcSEcCtD
Nicardipine—Diarrhoea—Estropipate—osteoporosis	0.000323	0.00138	CcSEcCtD
Nicardipine—Infection—Zoledronate—osteoporosis	0.000322	0.00137	CcSEcCtD
Nicardipine—Insomnia—Pamidronate—osteoporosis	0.000321	0.00137	CcSEcCtD
Nicardipine—Pain—Risedronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Nicardipine—Constipation—Risedronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Nicardipine—Shock—Zoledronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Nicardipine—Paraesthesia—Pamidronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Nicardipine—Diarrhoea—Alendronate—osteoporosis	0.000319	0.00136	CcSEcCtD
Nicardipine—Asthenia—Calcitriol—osteoporosis	0.000318	0.00136	CcSEcCtD
Nicardipine—Thrombocytopenia—Zoledronate—osteoporosis	0.000318	0.00135	CcSEcCtD
Nicardipine—Dyspnoea—Pamidronate—osteoporosis	0.000317	0.00135	CcSEcCtD
Nicardipine—Tachycardia—Zoledronate—osteoporosis	0.000317	0.00135	CcSEcCtD
Nicardipine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000316	0.00134	CcSEcCtD
Nicardipine—Somnolence—Pamidronate—osteoporosis	0.000316	0.00134	CcSEcCtD
Nicardipine—Hyperhidrosis—Zoledronate—osteoporosis	0.000314	0.00133	CcSEcCtD
Nicardipine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000313	0.00133	CcSEcCtD
Nicardipine—Diarrhoea—Raloxifene—osteoporosis	0.000313	0.00133	CcSEcCtD
Nicardipine—Dyspepsia—Pamidronate—osteoporosis	0.000313	0.00133	CcSEcCtD
Nicardipine—Dizziness—Estropipate—osteoporosis	0.000313	0.00133	CcSEcCtD
Nicardipine—Oedema—Conjugated Estrogens—osteoporosis	0.000312	0.00133	CcSEcCtD
Nicardipine—Infection—Conjugated Estrogens—osteoporosis	0.00031	0.00132	CcSEcCtD
Nicardipine—Diarrhoea—Ibandronate—osteoporosis	0.00031	0.00132	CcSEcCtD
Nicardipine—Dizziness—Alendronate—osteoporosis	0.000308	0.00131	CcSEcCtD
Nicardipine—Shock—Conjugated Estrogens—osteoporosis	0.000307	0.00131	CcSEcCtD
Nicardipine—Gastrointestinal pain—Risedronate—osteoporosis	0.000305	0.0013	CcSEcCtD
Nicardipine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000305	0.0013	CcSEcCtD
Nicardipine—Pain—Pamidronate—osteoporosis	0.000304	0.00129	CcSEcCtD
Nicardipine—Constipation—Pamidronate—osteoporosis	0.000304	0.00129	CcSEcCtD
Nicardipine—Diarrhoea—Calcitriol—osteoporosis	0.000304	0.00129	CcSEcCtD
Nicardipine—Hypotension—Zoledronate—osteoporosis	0.000303	0.00129	CcSEcCtD
Nicardipine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000303	0.00129	CcSEcCtD
Nicardipine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000303	0.00129	CcSEcCtD
Nicardipine—Dizziness—Raloxifene—osteoporosis	0.000303	0.00129	CcSEcCtD
Nicardipine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000302	0.00129	CcSEcCtD
Nicardipine—Tension—Estradiol—osteoporosis	0.000301	0.00128	CcSEcCtD
Nicardipine—Vomiting—Estropipate—osteoporosis	0.000301	0.00128	CcSEcCtD
Nicardipine—Dizziness—Ibandronate—osteoporosis	0.0003	0.00128	CcSEcCtD
Nicardipine—Rash—Estropipate—osteoporosis	0.000298	0.00127	CcSEcCtD
Nicardipine—Dermatitis—Estropipate—osteoporosis	0.000298	0.00127	CcSEcCtD
Nicardipine—Nervousness—Estradiol—osteoporosis	0.000297	0.00127	CcSEcCtD
Nicardipine—Headache—Estropipate—osteoporosis	0.000296	0.00126	CcSEcCtD
Nicardipine—Vomiting—Alendronate—osteoporosis	0.000296	0.00126	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000296	0.00126	CcSEcCtD
Nicardipine—Abdominal pain—Risedronate—osteoporosis	0.000295	0.00126	CcSEcCtD
Nicardipine—Body temperature increased—Risedronate—osteoporosis	0.000295	0.00126	CcSEcCtD
Nicardipine—Rash—Alendronate—osteoporosis	0.000294	0.00125	CcSEcCtD
Nicardipine—Insomnia—Zoledronate—osteoporosis	0.000293	0.00125	CcSEcCtD
Nicardipine—Dermatitis—Alendronate—osteoporosis	0.000293	0.00125	CcSEcCtD
Nicardipine—Feeling abnormal—Pamidronate—osteoporosis	0.000293	0.00125	CcSEcCtD
Nicardipine—Hypotension—Conjugated Estrogens—osteoporosis	0.000292	0.00124	CcSEcCtD
Nicardipine—Headache—Alendronate—osteoporosis	0.000292	0.00124	CcSEcCtD
Nicardipine—Paraesthesia—Zoledronate—osteoporosis	0.000291	0.00124	CcSEcCtD
Nicardipine—Vomiting—Raloxifene—osteoporosis	0.000291	0.00124	CcSEcCtD
Nicardipine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00029	0.00124	CcSEcCtD
Nicardipine—Dyspnoea—Zoledronate—osteoporosis	0.000289	0.00123	CcSEcCtD
Nicardipine—Rash—Raloxifene—osteoporosis	0.000289	0.00123	CcSEcCtD
Nicardipine—Dermatitis—Raloxifene—osteoporosis	0.000288	0.00123	CcSEcCtD
Nicardipine—Somnolence—Zoledronate—osteoporosis	0.000288	0.00123	CcSEcCtD
Nicardipine—Vomiting—Ibandronate—osteoporosis	0.000288	0.00123	CcSEcCtD
Nicardipine—Tremor—Estradiol—osteoporosis	0.000287	0.00122	CcSEcCtD
Nicardipine—Headache—Raloxifene—osteoporosis	0.000287	0.00122	CcSEcCtD
Nicardipine—Rash—Ibandronate—osteoporosis	0.000286	0.00122	CcSEcCtD
Nicardipine—Dermatitis—Ibandronate—osteoporosis	0.000286	0.00122	CcSEcCtD
Nicardipine—Dyspepsia—Zoledronate—osteoporosis	0.000286	0.00122	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000285	0.00121	CcSEcCtD
Nicardipine—Ill-defined disorder—Estradiol—osteoporosis	0.000284	0.00121	CcSEcCtD
Nicardipine—Headache—Ibandronate—osteoporosis	0.000284	0.00121	CcSEcCtD
Nicardipine—Insomnia—Conjugated Estrogens—osteoporosis	0.000283	0.0012	CcSEcCtD
Nicardipine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000282	0.0012	CcSEcCtD
Nicardipine—Vomiting—Calcitriol—osteoporosis	0.000282	0.0012	CcSEcCtD
Nicardipine—Agitation—Estradiol—osteoporosis	0.000281	0.0012	CcSEcCtD
Nicardipine—Nausea—Estropipate—osteoporosis	0.000281	0.0012	CcSEcCtD
Nicardipine—Abdominal pain—Pamidronate—osteoporosis	0.000281	0.00119	CcSEcCtD
Nicardipine—Body temperature increased—Pamidronate—osteoporosis	0.000281	0.00119	CcSEcCtD
Nicardipine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00028	0.00119	CcSEcCtD
Nicardipine—Rash—Calcitriol—osteoporosis	0.00028	0.00119	CcSEcCtD
Nicardipine—Dermatitis—Calcitriol—osteoporosis	0.00028	0.00119	CcSEcCtD
Nicardipine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000278	0.00119	CcSEcCtD
Nicardipine—Headache—Calcitriol—osteoporosis	0.000278	0.00118	CcSEcCtD
Nicardipine—Somnolence—Conjugated Estrogens—osteoporosis	0.000278	0.00118	CcSEcCtD
Nicardipine—Constipation—Zoledronate—osteoporosis	0.000277	0.00118	CcSEcCtD
Nicardipine—Pain—Zoledronate—osteoporosis	0.000277	0.00118	CcSEcCtD
Nicardipine—Nausea—Alendronate—osteoporosis	0.000277	0.00118	CcSEcCtD
Nicardipine—Malaise—Estradiol—osteoporosis	0.000276	0.00118	CcSEcCtD
Nicardipine—Hypersensitivity—Risedronate—osteoporosis	0.000275	0.00117	CcSEcCtD
Nicardipine—Vertigo—Estradiol—osteoporosis	0.000275	0.00117	CcSEcCtD
Nicardipine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000275	0.00117	CcSEcCtD
Nicardipine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000275	0.00117	CcSEcCtD
Nicardipine—Syncope—Estradiol—osteoporosis	0.000275	0.00117	CcSEcCtD
Nicardipine—Nausea—Raloxifene—osteoporosis	0.000272	0.00116	CcSEcCtD
Nicardipine—Palpitations—Estradiol—osteoporosis	0.000271	0.00115	CcSEcCtD
Nicardipine—Nausea—Ibandronate—osteoporosis	0.000269	0.00115	CcSEcCtD
Nicardipine—Loss of consciousness—Estradiol—osteoporosis	0.000269	0.00115	CcSEcCtD
Nicardipine—Asthenia—Risedronate—osteoporosis	0.000268	0.00114	CcSEcCtD
Nicardipine—Feeling abnormal—Zoledronate—osteoporosis	0.000267	0.00114	CcSEcCtD
Nicardipine—Constipation—Conjugated Estrogens—osteoporosis	0.000267	0.00114	CcSEcCtD
Nicardipine—Pain—Conjugated Estrogens—osteoporosis	0.000267	0.00114	CcSEcCtD
Nicardipine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000265	0.00113	CcSEcCtD
Nicardipine—Hypertension—Estradiol—osteoporosis	0.000264	0.00113	CcSEcCtD
Nicardipine—Nausea—Calcitriol—osteoporosis	0.000264	0.00112	CcSEcCtD
Nicardipine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000262	0.00112	CcSEcCtD
Nicardipine—Hypersensitivity—Pamidronate—osteoporosis	0.000262	0.00111	CcSEcCtD
Nicardipine—Arthralgia—Estradiol—osteoporosis	0.000261	0.00111	CcSEcCtD
Nicardipine—Chest pain—Estradiol—osteoporosis	0.000261	0.00111	CcSEcCtD
Nicardipine—Myalgia—Estradiol—osteoporosis	0.000261	0.00111	CcSEcCtD
Nicardipine—Anxiety—Estradiol—osteoporosis	0.00026	0.00111	CcSEcCtD
Nicardipine—Discomfort—Estradiol—osteoporosis	0.000258	0.0011	CcSEcCtD
Nicardipine—Abdominal pain—Zoledronate—osteoporosis	0.000256	0.00109	CcSEcCtD
Nicardipine—Body temperature increased—Zoledronate—osteoporosis	0.000256	0.00109	CcSEcCtD
Nicardipine—Diarrhoea—Risedronate—osteoporosis	0.000256	0.00109	CcSEcCtD
Nicardipine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000255	0.00109	CcSEcCtD
Nicardipine—Dry mouth—Estradiol—osteoporosis	0.000255	0.00109	CcSEcCtD
Nicardipine—Asthenia—Pamidronate—osteoporosis	0.000255	0.00108	CcSEcCtD
Nicardipine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000253	0.00108	CcSEcCtD
Nicardipine—Confusional state—Estradiol—osteoporosis	0.000252	0.00107	CcSEcCtD
Nicardipine—Oedema—Estradiol—osteoporosis	0.00025	0.00106	CcSEcCtD
Nicardipine—Infection—Estradiol—osteoporosis	0.000248	0.00106	CcSEcCtD
Nicardipine—Dizziness—Risedronate—osteoporosis	0.000247	0.00105	CcSEcCtD
Nicardipine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000247	0.00105	CcSEcCtD
Nicardipine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000247	0.00105	CcSEcCtD
Nicardipine—Shock—Estradiol—osteoporosis	0.000246	0.00105	CcSEcCtD
Nicardipine—Tachycardia—Estradiol—osteoporosis	0.000244	0.00104	CcSEcCtD
Nicardipine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000244	0.00104	CcSEcCtD
Nicardipine—Diarrhoea—Pamidronate—osteoporosis	0.000243	0.00103	CcSEcCtD
Nicardipine—Hyperhidrosis—Estradiol—osteoporosis	0.000242	0.00103	CcSEcCtD
Nicardipine—Rash—Ethinyl Estradiol—osteoporosis	0.000242	0.00103	CcSEcCtD
Nicardipine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000241	0.00103	CcSEcCtD
Nicardipine—Headache—Ethinyl Estradiol—osteoporosis	0.00024	0.00102	CcSEcCtD
Nicardipine—Hypersensitivity—Zoledronate—osteoporosis	0.000239	0.00102	CcSEcCtD
Nicardipine—Vomiting—Risedronate—osteoporosis	0.000238	0.00101	CcSEcCtD
Nicardipine—Rash—Risedronate—osteoporosis	0.000236	0.001	CcSEcCtD
Nicardipine—Dermatitis—Risedronate—osteoporosis	0.000235	0.001	CcSEcCtD
Nicardipine—Dizziness—Pamidronate—osteoporosis	0.000235	0.000999	CcSEcCtD
Nicardipine—Headache—Risedronate—osteoporosis	0.000234	0.000996	CcSEcCtD
Nicardipine—Asthenia—Zoledronate—osteoporosis	0.000233	0.000991	CcSEcCtD
Nicardipine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00023	0.000979	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000228	0.000969	CcSEcCtD
Nicardipine—Nausea—Ethinyl Estradiol—osteoporosis	0.000228	0.000969	CcSEcCtD
Nicardipine—Insomnia—Estradiol—osteoporosis	0.000226	0.000962	CcSEcCtD
Nicardipine—Vomiting—Pamidronate—osteoporosis	0.000226	0.000961	CcSEcCtD
Nicardipine—Paraesthesia—Estradiol—osteoporosis	0.000224	0.000955	CcSEcCtD
Nicardipine—Asthenia—Conjugated Estrogens—osteoporosis	0.000224	0.000954	CcSEcCtD
Nicardipine—Rash—Pamidronate—osteoporosis	0.000224	0.000953	CcSEcCtD
Nicardipine—Dermatitis—Pamidronate—osteoporosis	0.000224	0.000952	CcSEcCtD
Nicardipine—Dyspnoea—Estradiol—osteoporosis	0.000223	0.000949	CcSEcCtD
Nicardipine—Headache—Pamidronate—osteoporosis	0.000222	0.000947	CcSEcCtD
Nicardipine—Somnolence—Estradiol—osteoporosis	0.000222	0.000946	CcSEcCtD
Nicardipine—Diarrhoea—Zoledronate—osteoporosis	0.000222	0.000945	CcSEcCtD
Nicardipine—Nausea—Risedronate—osteoporosis	0.000222	0.000944	CcSEcCtD
Nicardipine—Dyspepsia—Estradiol—osteoporosis	0.00022	0.000937	CcSEcCtD
Nicardipine—Dizziness—Zoledronate—osteoporosis	0.000215	0.000913	CcSEcCtD
Nicardipine—Pain—Estradiol—osteoporosis	0.000214	0.00091	CcSEcCtD
Nicardipine—Constipation—Estradiol—osteoporosis	0.000214	0.00091	CcSEcCtD
Nicardipine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000214	0.00091	CcSEcCtD
Nicardipine—Nausea—Pamidronate—osteoporosis	0.000211	0.000898	CcSEcCtD
Nicardipine—Dizziness—Conjugated Estrogens—osteoporosis	0.000207	0.000879	CcSEcCtD
Nicardipine—Vomiting—Zoledronate—osteoporosis	0.000206	0.000878	CcSEcCtD
Nicardipine—Feeling abnormal—Estradiol—osteoporosis	0.000206	0.000877	CcSEcCtD
Nicardipine—Rash—Zoledronate—osteoporosis	0.000205	0.00087	CcSEcCtD
Nicardipine—Gastrointestinal pain—Estradiol—osteoporosis	0.000204	0.00087	CcSEcCtD
Nicardipine—Dermatitis—Zoledronate—osteoporosis	0.000204	0.00087	CcSEcCtD
Nicardipine—Headache—Zoledronate—osteoporosis	0.000203	0.000865	CcSEcCtD
Nicardipine—Vomiting—Conjugated Estrogens—osteoporosis	0.000199	0.000845	CcSEcCtD
Nicardipine—Body temperature increased—Estradiol—osteoporosis	0.000198	0.000841	CcSEcCtD
Nicardipine—Abdominal pain—Estradiol—osteoporosis	0.000198	0.000841	CcSEcCtD
Nicardipine—Rash—Conjugated Estrogens—osteoporosis	0.000197	0.000838	CcSEcCtD
Nicardipine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000197	0.000837	CcSEcCtD
Nicardipine—Headache—Conjugated Estrogens—osteoporosis	0.000196	0.000833	CcSEcCtD
Nicardipine—Nausea—Zoledronate—osteoporosis	0.000193	0.00082	CcSEcCtD
Nicardipine—Nausea—Conjugated Estrogens—osteoporosis	0.000186	0.00079	CcSEcCtD
Nicardipine—Hypersensitivity—Estradiol—osteoporosis	0.000184	0.000784	CcSEcCtD
Nicardipine—Asthenia—Estradiol—osteoporosis	0.000179	0.000763	CcSEcCtD
Nicardipine—Diarrhoea—Estradiol—osteoporosis	0.000171	0.000728	CcSEcCtD
Nicardipine—Dizziness—Estradiol—osteoporosis	0.000165	0.000704	CcSEcCtD
Nicardipine—Vomiting—Estradiol—osteoporosis	0.000159	0.000676	CcSEcCtD
Nicardipine—Rash—Estradiol—osteoporosis	0.000158	0.000671	CcSEcCtD
Nicardipine—Dermatitis—Estradiol—osteoporosis	0.000157	0.00067	CcSEcCtD
Nicardipine—Headache—Estradiol—osteoporosis	0.000157	0.000667	CcSEcCtD
Nicardipine—Nausea—Estradiol—osteoporosis	0.000148	0.000632	CcSEcCtD
Nicardipine—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.12e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IRS1—osteoporosis	9.11e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ENO1—osteoporosis	9.09e-06	4.6e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PSMA2—osteoporosis	9.03e-06	4.57e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PSMA5—osteoporosis	9.03e-06	4.57e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	9.01e-06	4.56e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PSMA2—osteoporosis	8.96e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PSMA5—osteoporosis	8.96e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KL—osteoporosis	8.95e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6R—osteoporosis	8.94e-06	4.52e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CYP19A1—osteoporosis	8.93e-06	4.52e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MTHFR—osteoporosis	8.91e-06	4.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MTHFR—osteoporosis	8.91e-06	4.51e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ACP5—osteoporosis	8.87e-06	4.49e-05	CbGpPWpGaD
Nicardipine—PDE1A—Disease—IL6—osteoporosis	8.82e-06	4.47e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IGF1—osteoporosis	8.81e-06	4.46e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—POMC—osteoporosis	8.78e-06	4.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TGFB1—osteoporosis	8.77e-06	4.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IRS2—osteoporosis	8.76e-06	4.43e-05	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL6—osteoporosis	8.74e-06	4.42e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—POMC—osteoporosis	8.73e-06	4.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KL—osteoporosis	8.66e-06	4.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KL—osteoporosis	8.66e-06	4.38e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—ADCY5—osteoporosis	8.62e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—GPX1—osteoporosis	8.59e-06	4.35e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	8.57e-06	4.34e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6R—osteoporosis	8.56e-06	4.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6R—osteoporosis	8.52e-06	4.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TGFB1—osteoporosis	8.49e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TGFB1—osteoporosis	8.49e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IRS2—osteoporosis	8.47e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IRS2—osteoporosis	8.47e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—POMC—osteoporosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—POMC—osteoporosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IGF1—osteoporosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—ADCY5—osteoporosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—ADCY5—osteoporosis	8.42e-06	4.26e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—GPX1—osteoporosis	8.41e-06	4.26e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	8.4e-06	4.25e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—GPX1—osteoporosis	8.39e-06	4.25e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—ADCY5—osteoporosis	8.38e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	8.37e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—GPX1—osteoporosis	8.36e-06	4.23e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	8.29e-06	4.2e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IRS1—osteoporosis	8.28e-06	4.19e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	8.27e-06	4.19e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—POMC—osteoporosis	8.25e-06	4.18e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TPI1—osteoporosis	8.25e-06	4.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6R—osteoporosis	8.24e-06	4.17e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6R—osteoporosis	8.24e-06	4.17e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MYC—osteoporosis	8.22e-06	4.16e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TGFB1—osteoporosis	8.2e-06	4.15e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	8.15e-06	4.12e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SPP1—osteoporosis	8.13e-06	4.11e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ADCY5—osteoporosis	8.11e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ADCY5—osteoporosis	8.11e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SPP1—osteoporosis	8.1e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—GPX1—osteoporosis	8.08e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—GPX1—osteoporosis	8.08e-06	4.09e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—IL6—osteoporosis	8.07e-06	4.08e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	8.05e-06	4.07e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SPP1—osteoporosis	8.02e-06	4.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IRS1—osteoporosis	8.01e-06	4.05e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IRS1—osteoporosis	8.01e-06	4.05e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	8e-06	4.05e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—LEP—osteoporosis	7.97e-06	4.03e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CYP19A1—osteoporosis	7.97e-06	4.03e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	7.94e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—MTHFR—osteoporosis	7.92e-06	4.01e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6R—osteoporosis	7.78e-06	3.94e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CYP19A1—osteoporosis	7.78e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—MTHFR—osteoporosis	7.76e-06	3.93e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—P4HB—osteoporosis	7.76e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—MTHFR—osteoporosis	7.75e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—MTHFR—osteoporosis	7.71e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IRS1—osteoporosis	7.65e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.61e-06	3.85e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	7.61e-06	3.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6R—osteoporosis	7.53e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6R—osteoporosis	7.53e-06	3.81e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MYC—osteoporosis	7.52e-06	3.8e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TGFB1—osteoporosis	7.5e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—MTHFR—osteoporosis	7.46e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—MTHFR—osteoporosis	7.46e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—RAP1A—osteoporosis	7.41e-06	3.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IRS1—osteoporosis	7.4e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IRS1—osteoporosis	7.4e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—POMC—osteoporosis	7.37e-06	3.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IRS2—osteoporosis	7.35e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CYP19A1—osteoporosis	7.33e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IRS2—osteoporosis	7.33e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ADCY5—osteoporosis	7.29e-06	3.69e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GPX1—osteoporosis	7.27e-06	3.68e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.27e-06	3.68e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IRS2—osteoporosis	7.26e-06	3.67e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	7.24e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—LEP—osteoporosis	7.19e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6R—osteoporosis	7.18e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—LEP—osteoporosis	7.17e-06	3.63e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	7.11e-06	3.6e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—LEP—osteoporosis	7.1e-06	3.59e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—LEP—osteoporosis	7.08e-06	3.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ADCY5—osteoporosis	7.01e-06	3.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6R—osteoporosis	6.95e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6R—osteoporosis	6.95e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ESR1—osteoporosis	6.87e-06	3.48e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—POMC—osteoporosis	6.85e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ESR1—osteoporosis	6.85e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SPP1—osteoporosis	6.78e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ADCY5—osteoporosis	6.78e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ADCY5—osteoporosis	6.78e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ESR1—osteoporosis	6.78e-06	3.43e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	6.76e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL6—osteoporosis	6.74e-06	3.41e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—MTHFR—osteoporosis	6.71e-06	3.39e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	6.68e-06	3.38e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	6.59e-06	3.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SPP1—osteoporosis	6.56e-06	3.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SPP1—osteoporosis	6.56e-06	3.32e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ADCY5—osteoporosis	6.51e-06	3.29e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GPX1—osteoporosis	6.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL6—osteoporosis	6.46e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IRS1—osteoporosis	6.42e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IRS1—osteoporosis	6.4e-06	3.24e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ADCY5—osteoporosis	6.35e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—POMC—osteoporosis	6.34e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IRS1—osteoporosis	6.33e-06	3.21e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GPX1—osteoporosis	6.33e-06	3.2e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	6.32e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—POMC—osteoporosis	6.21e-06	3.14e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—POMC—osteoporosis	6.19e-06	3.13e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL6—osteoporosis	6.18e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—POMC—osteoporosis	6.18e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—POMC—osteoporosis	6.17e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—POMC—osteoporosis	6.16e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IRS2—osteoporosis	6.13e-06	3.1e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—POMC—osteoporosis	6.1e-06	3.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.08e-06	3.08e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	6.07e-06	3.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.03e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6R—osteoporosis	6.01e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—LEP—osteoporosis	6e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ENO1—osteoporosis	5.99e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ADCY5—osteoporosis	5.99e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—MTHFR—osteoporosis	5.99e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GPX1—osteoporosis	5.97e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—POMC—osteoporosis	5.97e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—POMC—osteoporosis	5.97e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—IL6—osteoporosis	5.95e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6R—osteoporosis	5.95e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IGF1—osteoporosis	5.94e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ADCY5—osteoporosis	5.94e-06	3e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IRS2—osteoporosis	5.93e-06	3e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IRS2—osteoporosis	5.93e-06	3e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	5.93e-06	3e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF1—osteoporosis	5.92e-06	3e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1B—osteoporosis	5.92e-06	3e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GPX1—osteoporosis	5.92e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.91e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.91e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF1—osteoporosis	5.87e-06	2.97e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	5.85e-06	2.96e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—MTHFR—osteoporosis	5.84e-06	2.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—LEP—osteoporosis	5.81e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—LEP—osteoporosis	5.81e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—osteoporosis	5.76e-06	2.91e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—osteoporosis	5.76e-06	2.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ESR1—osteoporosis	5.73e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1B—osteoporosis	5.73e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1B—osteoporosis	5.73e-06	2.9e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—osteoporosis	5.65e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ESR1—osteoporosis	5.54e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ESR1—osteoporosis	5.54e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.51e-06	2.79e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—MTHFR—osteoporosis	5.46e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—POMC—osteoporosis	5.37e-06	2.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IRS1—osteoporosis	5.36e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—osteoporosis	5.3e-06	2.68e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	5.28e-06	2.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IRS1—osteoporosis	5.18e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IRS1—osteoporosis	5.18e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—POMC—osteoporosis	5.16e-06	2.61e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—osteoporosis	5.07e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	5.06e-06	2.56e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	5.04e-06	2.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6R—osteoporosis	5.03e-06	2.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—POMC—osteoporosis	4.99e-06	2.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—POMC—osteoporosis	4.99e-06	2.52e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1—osteoporosis	4.96e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6R—osteoporosis	4.87e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6R—osteoporosis	4.87e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1—osteoporosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1—osteoporosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.79e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—POMC—osteoporosis	4.79e-06	2.42e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—osteoporosis	4.77e-06	2.41e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	4.76e-06	2.41e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—POMC—osteoporosis	4.67e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—osteoporosis	4.55e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—osteoporosis	4.53e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—osteoporosis	4.49e-06	2.27e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.47e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—POMC—osteoporosis	4.4e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—POMC—osteoporosis	4.37e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—osteoporosis	4.26e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—osteoporosis	4.25e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—osteoporosis	4.12e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—osteoporosis	4.12e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—osteoporosis	4.11e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—osteoporosis	4.11e-06	2.08e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—osteoporosis	3.98e-06	2.02e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—osteoporosis	3.96e-06	2e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	3.95e-06	2e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.92e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—osteoporosis	3.9e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—osteoporosis	3.81e-06	1.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—osteoporosis	3.79e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—osteoporosis	3.67e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—osteoporosis	3.67e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.6e-06	1.82e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—osteoporosis	3.59e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—osteoporosis	3.57e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3.56e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—osteoporosis	3.56e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	3.55e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—osteoporosis	3.53e-06	1.78e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	3.52e-06	1.78e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.52e-06	1.78e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.51e-06	1.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—osteoporosis	3.47e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—osteoporosis	3.35e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—osteoporosis	3.35e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—osteoporosis	3.2e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—osteoporosis	3.1e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—osteoporosis	3.1e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—osteoporosis	2.98e-06	1.51e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.98e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—osteoporosis	2.97e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—osteoporosis	2.88e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—osteoporosis	2.88e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—POMC—osteoporosis	2.88e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—osteoporosis	2.88e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—osteoporosis	2.88e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—osteoporosis	2.69e-06	1.36e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—osteoporosis	2.68e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—osteoporosis	2.65e-06	1.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.64e-06	1.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—osteoporosis	2.24e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—osteoporosis	2.17e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—osteoporosis	2.17e-06	1.1e-05	CbGpPWpGaD
